COPD Teaching 1760
SN instructed that Breo Ellipta is used regularly as a long term (maintenance) treatment to prevent or decrease wheezing and trouble breathing caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). Instructed that common side effects include, Headache, dry/irritated throat, hoarseness, runny nose, and coughing may occur as your body adjusts to the medication.
Reviewed November 2017
Reviewed for general reference only. Adapt to your patient, agency policy, and scope of practice.
Related teachings
COPD Teaching 835Instructed on the importance of avoiding/reducing exposure to crowds in order to reduce the risk of respiratory infections.COPD Teaching 1763SN instructed on new medication Spiriva is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis...COPD Teaching 831Instructed on some signs/symptoms of respiratory infection, such as: mucoid or purulent sputum and loss of appetite, among others.COPD Teaching 2454Instructed patient about breathing tips for people with COPD get fresh air, try to avoid other things that can bother your lungs, too. Stay inside on days when you know pollution or pollen is bad. Stay away from fumes an...